Literature DB >> 18249026

Diabetic retinopathy and systemic vascular complications.

Ning Cheung1, Tien Y Wong.   

Abstract

Retinopathy is the most common complication of diabetes. The assessment of retinopathy signs presents clinicians a unique opportunity to directly visualize and assess the actual morphology of diabetic microvascular damage. Extensive studies have now shown that people with diabetic retinopathy have excess risks of systemic vascular complications, including subclinical and clinical stroke, coronary heart disease, heart failure, and nephropathy. There is also emerging evidence to suggest that diabetic retinopathy may share common genetic linkages with systemic vascular complications. The extant literature, therefore, supports the theory that diabetic retinopathy reflects widespread microcirculatory disease not only in the eye but also vital organs elsewhere in the body. Being a uniquely specific and non-invasively assessable measure of diabetic microvascular damage, retinopathy may also be envisioned as a novel biomarker of vascular disease risk in asymptomatic patients with diabetes. This review summarizes recent studies on the systemic associations of diabetic retinopathy, and discusses their pathophysiological significance and clinical implications.

Entities:  

Mesh:

Year:  2007        PMID: 18249026     DOI: 10.1016/j.preteyeres.2007.12.001

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  70 in total

1.  Early visual cortical structural changes in diabetic patients without diabetic retinopathy.

Authors:  Fábio S Ferreira; João M S Pereira; Aldina Reis; Mafalda Sanches; João V Duarte; Leonor Gomes; Carolina Moreno; Miguel Castelo-Branco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-04       Impact factor: 3.117

Review 2.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes.

Authors:  N Malandrino; W C Wu; T H Taveira; H B Whitlatch; R J Smith
Journal:  Diabetologia       Date:  2011-10-15       Impact factor: 10.122

Review 4.  The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes.

Authors:  Carol Yimlui Cheung; M Kamran Ikram; Ronald Klein; Tien Yin Wong
Journal:  Diabetologia       Date:  2015-02-11       Impact factor: 10.122

5.  Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study.

Authors:  Ning Cheung; Sophie Rogers; Thomas H Mosley; Ronald Klein; David Couper; Tien Y Wong
Journal:  Psychosom Med       Date:  2008-12-10       Impact factor: 4.312

6.  Sleep apnea and retinal signs in cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Merwyn Chew; Jing Xie; Ronald Klein; Barbara Klein; Mary Frances Cotch; Susan Redline; Tien Yin Wong; Ning Cheung
Journal:  Sleep Breath       Date:  2015-04-24       Impact factor: 2.816

7.  Assessment of vascular regeneration in the CNS using the mouse retina.

Authors:  Khalil Miloudi; Agnieszka Dejda; François Binet; Eric Lapalme; Agustin Cerani; Przemyslaw Sapieha
Journal:  J Vis Exp       Date:  2014-06-23       Impact factor: 1.355

8.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

9.  Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Jie Ding; Mark W J Strachan; Rebecca M Reynolds; Brian M Frier; Ian J Deary; F Gerald R Fowkes; Amanda J Lee; Janet McKnight; Patricia Halpin; Ken Swa; Jackie F Price
Journal:  Diabetes       Date:  2010-08-26       Impact factor: 9.461

10.  Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy.

Authors:  Thanh T Nguyen; Ryo Kawasaki; Jie Jin Wang; Andreas J Kreis; Jonathan Shaw; Walthard Vilser; Tien Y Wong
Journal:  Diabetes Care       Date:  2009-07-29       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.